Temporal trends in results of endovascular treatment of anterior intracranial large cerebral vessel occlusion: A 7-year study.


Journal

European stroke journal
ISSN: 2396-9881
Titre abrégé: Eur Stroke J
Pays: England
ID NLM: 101688446

Informations de publication

Date de publication:
09 2023
Historique:
medline: 31 8 2023
pubmed: 8 6 2023
entrez: 8 6 2023
Statut: ppublish

Résumé

Technical improvements in devices, changes in angiographic grading scales and various confounding factors have made difficult the detection of the temporal evolution of angiographic and clinical results after endovascular treatment (EVT) for acute ischemic Stroke (AIS). We analyzed this evolution in time using the Endovascular Treatment in Ischemic Stroke (ETIS) registry. We analyzed the efficacy outcomes of EVT performed from January 2015 to January 2022, and modelized the temporal trends using mixed logistic regression models, further adjusted for age, intravenous thrombolysis prior to EVT, general anesthesia, occlusion site, balloon catheter use and the type of first-line EVT strategy. We assessed heterogeneity in temporal trends according to occlusion site, balloon catheter use, cardio embolic etiology, age (<80 years vs ⩾80 years) and first-line EVT strategy. Among 6104 patients treated from 2015 to 2021, the rates of successful reperfusion (71.1%-89.6%) and of complete first pass effect (FPE) (4.6%-28.9%) increase, whereas the rates of patients with >3 EVT device passes (43.1%-17.5%) and favorable outcome (35.8%-28.9%) decrease significantly over time. A significant heterogeneity in temporal trends in successful reperfusion according to the first-line EVT strategy was found (p-het = 0.018). The temporal trend of increasing successful reperfusion rate was only significant in patients treated with contact aspiration in first-line (adjusted overall effect In this 7-year-old large registry of ischemic stroke cases treated with EVT, we observed a significant increase with time in the rate of recanalization whereas there was a tendency toward a decrease in the rate of favorable outcome over the same period.

Sections du résumé

BACKGROUND
Technical improvements in devices, changes in angiographic grading scales and various confounding factors have made difficult the detection of the temporal evolution of angiographic and clinical results after endovascular treatment (EVT) for acute ischemic Stroke (AIS). We analyzed this evolution in time using the Endovascular Treatment in Ischemic Stroke (ETIS) registry.
MATERIALS AND METHODS
We analyzed the efficacy outcomes of EVT performed from January 2015 to January 2022, and modelized the temporal trends using mixed logistic regression models, further adjusted for age, intravenous thrombolysis prior to EVT, general anesthesia, occlusion site, balloon catheter use and the type of first-line EVT strategy. We assessed heterogeneity in temporal trends according to occlusion site, balloon catheter use, cardio embolic etiology, age (<80 years vs ⩾80 years) and first-line EVT strategy.
RESULTS
Among 6104 patients treated from 2015 to 2021, the rates of successful reperfusion (71.1%-89.6%) and of complete first pass effect (FPE) (4.6%-28.9%) increase, whereas the rates of patients with >3 EVT device passes (43.1%-17.5%) and favorable outcome (35.8%-28.9%) decrease significantly over time. A significant heterogeneity in temporal trends in successful reperfusion according to the first-line EVT strategy was found (p-het = 0.018). The temporal trend of increasing successful reperfusion rate was only significant in patients treated with contact aspiration in first-line (adjusted overall effect
CONCLUSION
In this 7-year-old large registry of ischemic stroke cases treated with EVT, we observed a significant increase with time in the rate of recanalization whereas there was a tendency toward a decrease in the rate of favorable outcome over the same period.

Identifiants

pubmed: 37288701
doi: 10.1177/23969873231180338
pmc: PMC10472952
doi:

Banques de données

ClinicalTrials.gov
['NCT03776877']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

655-666

Références

N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
J Neurointerv Surg. 2019 Jul;11(7):625-629
pubmed: 30389897
Stroke. 2018 May;49(5):1189-1196
pubmed: 29626134
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
J Neurointerv Surg. 2018 Sep;10(9):907-910
pubmed: 29352061
Int J Stroke. 2015 Oct;10 Suppl A100:128-35
pubmed: 26146766
Front Neurol. 2022 Jun 30;13:925159
pubmed: 35847206
J Neurointerv Surg. 2017 Dec;9(12):1154-1159
pubmed: 27986848
Stroke. 2021 Aug;52(9):2736-2742
pubmed: 34233462
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
AJNR Am J Neuroradiol. 2012 Apr;33(4):643-8
pubmed: 22207297
J Neuroradiol. 2020 Jun;47(4):301-305
pubmed: 30951765
J Neurointerv Surg. 2023 Sep;15(e1):e111-e116
pubmed: 35918126
AJNR Am J Neuroradiol. 2010 May;31(5):935-9
pubmed: 20075091
J Neurointerv Surg. 2019 Apr;11(4):328-333
pubmed: 30154254
J Neurointerv Surg. 2014 Mar;6(2):83-6
pubmed: 23390038
J Neurointerv Surg. 2018 Jan;10(1):34-38
pubmed: 28044009
Stroke. 2018 Sep;49(9):2088-2095
pubmed: 30354993
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
Neurosurgery. 2020 Dec 15;88(1):E83-E90
pubmed: 32717034
J Neurointerv Surg. 2019 May;11(5):433-438
pubmed: 30194109
Eur Neurol. 2019;81(3-4):174-181
pubmed: 31291626
Stroke. 2022 Jun;53(6):1863-1872
pubmed: 35135323
Stroke. 2016 Dec;47(12):3035-3037
pubmed: 27780903
Stroke Vasc Neurol. 2023 Aug;8(4):318-326
pubmed: 36720506
Stroke. 2018 Mar;49(3):660-666
pubmed: 29459390
Cardiovasc Intervent Radiol. 2012 Dec;35(6):1332-9
pubmed: 22167306
J Neurointerv Surg. 2017 Feb;9(2):117-121
pubmed: 26888952
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
J Stroke Cerebrovasc Dis. 2016 Apr;25(4):954-9
pubmed: 26851970
Interv Neuroradiol. 2016 Jun;22(3):325-32
pubmed: 26908591
Stroke. 1999 Nov;30(11):2280-4
pubmed: 10548658
J Neurointerv Surg. 2016 Nov;8(11):1123-1128
pubmed: 26667250
AJNR Am J Neuroradiol. 2007 Feb;28(2):382-4
pubmed: 17297017
Stroke. 2020 Jul;51(7):2012-2017
pubmed: 32432994
Lancet Neurol. 2016 Oct;15(11):1138-47
pubmed: 27567239
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Stroke. 2015 Oct;46(10):3020-35
pubmed: 26123479
Stroke. 2018 Oct;49(10):2523-2525
pubmed: 30355115
AJNR Am J Neuroradiol. 2017 Jan;38(1):90-96
pubmed: 27811134
Lancet. 1998 Oct 17;352(9136):1245-51
pubmed: 9788453
Stroke. 2018 May;49(5):1286-1289
pubmed: 29618557
Stroke. 2019 May;50(5):1156-1163
pubmed: 31009342

Auteurs

Romain Bourcier (R)

Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nantes, Nantes, France.

Arturo Consoli (A)

Department of Diagnostic and Therapeutic Neuroradiology, Hôpital Foch Suresnes FR, University of Versailles Saint Quentin-en-Yvelines, Saint Quentin-en-Yvelines, France.

Jean-Philippe Desilles (JP)

Department of Interventional Neuroradiology, Rothschild Foundation Hospital, INSERM unit 1148, Paris-Cité University, Paris, France.

Julien Labreuche (J)

EA 2694 - Santé publique: épidémiologie et qualité des soins, University of Lille, CHU Lille, Lille, France.

Maeva Kyheng (M)

EA 2694 - Santé publique: épidémiologie et qualité des soins, University of Lille, CHU Lille, Lille, France.

Hubert Desal (H)

Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nantes, Nantes, France.

Quentin Alias (Q)

Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Rennes, Rennes, France.

Benjamin Gory (B)

IADI, University of Lorraine, INSERM U1254, Nancy, France.
Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nancy, Nancy, France.

Cyril Dargazanli (C)

Department of Neuroradiology, Guy de Chauliac University Hospital, Montpellier, France.

Kévin Janot (K)

Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Tours, Tours, France.

François Zhu (F)

IADI, University of Lorraine, INSERM U1254, Nancy, France.
Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nancy, Nancy, France.

Bertrand Lapergue (B)

Department of Neurology, Hôpital Foch Suresnes FR, University of Versailles Saint Quentin-en-Yvelines, France.

Gaultier Marnat (G)

Department of Diagnostic and Interventional Neuroradiology, University Hospital, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH